What is Teligent?
Founded in 1977 and headquartered in Buena, New Jersey, Teligent specializes in the manufacturing of pharmaceutical products. The company serves both medical professionals and patients, providing essential pharmaceutical solutions. Its long operational history suggests a deep understanding of the pharmaceutical landscape and a sustained commitment to its market niche. The recent strategic investment indicates a renewed focus on scaling operations or developing new product lines within its established domain.
How much funding has Teligent raised?
Teligent has raised a total of $12M across 2 funding rounds:
Debt
$2M
Share Placement
$10M
Debt (2020): $2M with participation from PPP
Share Placement (2020): $10M, investors not publicly disclosed
Key Investors in Teligent
PPP
Public-Private Partnership
What's next for Teligent?
The substantial enterprise-level funding, particularly the recent strategic investment, positions Teligent for significant advancements. This capital infusion is likely to fuel research and development, enhance manufacturing capabilities, or facilitate market expansion. As a company with decades of experience, Teligent is poised to leverage this financial backing to solidify its standing in the pharmaceutical manufacturing sector and potentially explore new avenues for growth and innovation. The company's strategic direction will be closely watched as it deploys these resources.
See full Teligent company page
